Growth factor therapy

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 4, Issue 3, 1998, Pages 212-222

  Conner, James M ^a   Tuszynski, Mark H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Brain derived neurotrophic factor; Ciliary neurotrophic factor; Fibroblast growth factor; Glial cell line derived neurotrophic factor; Leukemia inhibitory factor; Nerve growth factor; Neurodegeneration; Neurotrophic factor therapy; Neurotrophin 3; Parkinson's disease; Trophic factor

Indexed keywords

BRAIN DERIVED GROWTH FACTOR; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 1; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD BRAIN BARRIER; DRUG EFFECT; DRUG PENETRATION; HUMAN; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NERVE SPROUTING; NEUROTROPISM; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0031685561     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1998)4:3<212::AID-MRDD9>3.0.CO;2-P     Document Type: Review

References (171)

1. Aebischer P, Schluep M, Deglon N, et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogenic cells in amyotrophic lateral sclerosis patients. Nat Med 1996;2:696-699.
2. Agid Y. Parkinson's disease: pathophysiology. Lancet 1991;337:1321-1327.
3. Albin RL, Young AB, Penny JB. The functional anatomy of basal ganglia disorders. TINS 1989;12:366-375.
4. Aloe L, Levi-Montalcini R. Mast cells increase in tissue of neonatal rats injected with the nerve growth factor. Brain Res 1977;133:358-366.
5. Altar CA, Siuciak JA, Wright P, et al. In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125]BDNF, [125]NT-4/5 and [125]NT-3. Eur J Neurosci 1994;6.1389-1405.
6. Apfel SC, Kesslar JA. Neurotrophic factors in the treatment of peripheral neuropathies. In: Bock GR, Goode JA, eds. Growth Factors as Drugs for Neurological and Sensory Disorders. New York: John Wiley & Sons, 1996:98-108.
7. Apfel SC, Lipton RB, Arezzo JC, et al. Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 1991;29:87-90.
8. Apfel SC, Arezzo JC, Lipson LA, et al. Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992;31:76-80.
9. Apfel SC, Arezzo JC, Brownlee M, et al. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994;634:7-12.
10. Apfel SC, Wright DE, Wiidman AM, et al. Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system. Mol Cell Neurosci 1996;7:134-142.
11. Arakawa Y, Sendtner M, Thoenen H. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motorneurons in culture: comparison with other neurotrophic factors and cytokines. J Neurosci 1990;10:3507-3515.
12. Arenas E, Trupp M, Akerud P, et al. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 1995;15:1465-1473.
13. Barbacid M. The Trk family of neurotrophin receptors. J Neurobiol 1994;25:1386-1403.
14. Barde Y-A, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1983;1:549-553.
15. Barnett J, Baecker P, Routledge-Ward C, et al. Human beta nerve growth factor obtained from a baculovirus expression system has potent in vitro and in vivo neurotrophic activity. Exp Neurol 1990;110:11-24.
16. Bartus RT, Dean RL, Beer B, et al. The cholinergic hypothesis of genatric memory dysfunction. Science 1982;217:408-417.
17. Beck KD, Valverde J, Alexi T, et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995;373:339-341.
18. Beck KD, Irwin I, Valverde J, et al. GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 1996;16:665-673.
19. Beck T, Lindholm D, Castren E, et al. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab 1994;14:689-692.
20. Berg L, Morris JC. Diagnosis. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer's Disease. New York: Raven Press, 1994:9-25.
21. Bergado JA, Fernandez CI, Gomez-Soria A, et al. Chronic intraventricular infusion with NGF improves LTP in old cognitively-impaired rats. Brain Res 1997;770:1-9.
22. Berkemeier LR, Winslow JW, Kaplan DR, et al. Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 1991;7: 857-866.
23. Blakesley VA, Scrimgeour A, Esposito D, et al. Signaling via the insulin-like growth factor-1 receptor: does it differ from insulin receptor signaling? Cytokine Growth Factor Rev 1996;7:153-159.
24. Brown RH Jr. Amyotrophic lateral sclerosis. Insights from genetics. Arch Neurol 1997;54: 1246-1250.
25. Butcher LL, Woolf NJ. Neurotrophic agents may exacerbate the pathologic cascade of Alzheimer's disease. Neurobiol Aging 1989;10:557-570.
26. Cedarbaum JM, Chapman C, Charatan M, et al. A phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. Clin Neurophannacol 1995;18:515-532.
27. Chan K-M, Lam D-TN, Pong K, et al. Neurotrophin-4/5 treatment reduces infarct size in rats with middle cerebral artery occlusion. Neurochem Res 1996;21:769-773.
28. Chen KS, Gage FH. Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration. J Neurosci 1995;15:2819-2825.
29. Cheng H, Cao Y, Olson L. Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 1996;273:510-513.
30. Conner JM, Uy H, Tuszynski MH. Distribution of NGF delivered into the rat CNS by either grafted NGF-secreting fibroblasts, intraparentchymal injections, or intraparenchymal infusions Soc Neurosci Abstr 1997;23:53.
31. Contreras PC, Steffler C, Yu E, et al. Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush. J Pharmacol Exp Ther 1995;27:1443-1449.
32. Coyle JT, Price PH, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983;219:1184-1189.
33. Crutcher KA, Scott SA, Liang S, et al. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 1993;13:2540-2550.
34. Cummings BJ, Yee GJ, Cotman CW. Basic FGF promotes the survival of entorhinal layer II neurons after perforant path axotomy. Brain Res 1992;591:271-276.
35. Curtis R, Adryan KM, Zhu Y, et al. Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury. Nature 1993;365:253-255.
36. Davis KL, Thai LJ, Gamzu ER, et al. A doubleblind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992;237:1253-1259.
37. Dawbarn D, Allen SJ, Semenenko FM. Immunohistochemical localization of b-nerve growth factor receptors in the forebrain of the rat. Brain Res 1988;440:185-189.
38. Dekker AJ, Fagan AM, Gage FH, et al. Effects of brain-derived neurotrophic factor and nerve growth factor on remaining neurons in the lesioned nucleus basalis magnocellularis. Brain Res 1994;639:149-155.
39. Diemel LT, Brewster WJ, Fernhough P, et al. Expression of neuropeptides in experimental diabetes: effects of treatment with nerve growth factor or brain derived neurotrophic factor. Mol Brain Res 1994;21:171-175.
40. Dittrich F, Thoenen H, Sendtner M. Ciliary neurotrophic factor: pharmokinetics and acutephase response in rat. Ann Neurol 1994;35: 151-163.
41. Dobrowsky RT, Jenkins GM, Hannun YA. Neurotrophins induce sphingomyelin hydrolysis. Modulation by coexpression of p75NTR with trk receptors. J Biol Chem 1995;270: 22135-22142.
42. Duffy MT, Liebich DR, Gamer LK, et al. Axonal sprouting and frank regeneration in the lizard tail spinal cord: correlation between changes in synaptic circuitry and axonal growth J Comp Neurol 1992;316:363-374.
43. Dunnett SB, Svendsen CN. Huntington's disease: animal models and transplantation repair. Curr Opin Neurobiol 1993;3:790-796.
44. Eagger SA, Levy R, Sahakian BJ. Tacrine in Alzheimer's disease. Lancet 1991;337:989-992.
45. Eckenstein FP. Fibroblast growth factors in the nervous system. J Neurobiol 1994;25:1467-1480.
46. Emerich DF, Winn SR, Harper J, et al. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 1994;349: 148-164.
47. Emerich DF, Lindner MD, Winn SR, et al. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J Neurosci 1996;16: 5168-5181.
48. Emerich DF, Winn SR, Hantraye PM, et al. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 1997; 386:395-399.
49. Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Ann Rev Psychol 1997;45:649-684.
50. Figueiredo BC, Piccardo P, Maysinger D, et al. Effects of acidic fibroblast growth factor on cholinergic neurons of nucleus basalis magnocellularis and in spatial memory task following cortical devascularization. Neuroscience 1993; 56:955-963.
51. Fischer W, Wictorin K, Bjorklund A, et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987;329:65-68.
52. Fischer W, Sirevaag A, Wiegand SJ, et al. Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1994;91:8607-8611.
53. Fisher M, Meadows ME, Do T, et al. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1995;15:953-959.
54. Frade JM, Rodriguez-Tebar A, Barde Y-A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996;383:166-168.
55. Friden PM, Walus LR, Watson P, et al. Bloodbrain barrier penetration and in vivo activity of an NGF conjugate. Science 1993;259:373-377.
56. Friedman WJ, Ibanez CF, Hallbook F, et al. Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol 1993;119:72-78.
57. Frim DM, Uhler TA, Short MP, et al. Effects of biologically delivered NGF, BDNF and basic FGF on striatal excitotoxic lesions. Neuroreport 1993a;4:367-370.
58. Frim DM, Yee WM, Isacson O. NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress. Neuroreport 1993b;4:655-658.
59. Gage FH, Armstrong DM, Williams LR, et al. Morphological responses of axotomized septal neurons to nerve growth factor. J Comp Neurol 1988;269:147-155.
60. Gao W-Q, Dybdal N, Shinsky N, et al. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 1995;38:30-37.
61. Gash DM, Zhang Z, Ovadia A, et al. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature 1996;380:252-255.
62. Gluckman P, Klempt N, Guan J, et al. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 1992;182:593-599.
63. Grill R, Murai K, Blesch A, et al. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci 1997a;17: 5560-5572.
64. Grill RJ, Blesch A, Tuszynski MH. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol 1997b;148: 444-452.
65. Hagg T, Varon S. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra neurons and promotes low affinity NGF receptor expression on the adult rat CNS. Neuron 1993;8:145-158.
66. Hagg T, Gulati AK, Behzadian AM, et al. Nerve growth factor promotes CNS axonal regeneration into acellular peripheral nerve grafts. Exp Neurol 1990a;112:79-88.
67. Hagg T, Vahlsing HL, Manthorpe M, et al. Septo-hippocampal cholinergic axonal regeneration through peripheral nerve bridges: quantification and temporal development. Exp Neurol 1990b;109:153-163.
68. Hagg T, Vahlsing HL, Manthorpe M, et al. Nerve growth factor infusion into the denervated adult rat hippocampal formation promotes its cholinergic reinnervation. J Neurosci 1990c; 10:3087-3092.
69. Hagg T, Quon D, Higaki J, et al. Ciliary neurotrophic factor prevents neuronal degeneration and promotes low affinity NGF receptor expression in the adult rat CNS. Neuron 1992;8:145-158.
70. Hallböök F, Ibanez CF, Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in xenopus ovary. Neuron 1991;6:845-858.
71. Hantai D, Akaaboune M, Lagord C, et al. Beneficial effects of insulin-like growth factor-I on wobbler mouse motorneuron disease. J Neurol Sci 1995;129(Suppl):122-126.
72. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 1986;6:2155-2162.
73. Hefti F. Pharmacology of neurotrophic factors. Annu Rev Pharmacol Toxicol 1997;37:239-267.
74. Hellmich HL, Kos L, Cho ES, et al. Embryonic expression of glial cell line-derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech Dev 1996;54:95-105.
75. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: a potent survival factor for motorneurons present in peripheral nerve and muscle. Science 1994;266:1062-1064.
76. Hohn A, Leibrock J, Bailey K, et al. Identification and characterization of a novel member of the nerve growth factor/brain-derived growth neurotrophic factor family. Nature 1990;344: 339-341.
77. Holtzman DM, Li Y, Parada LF, et al. p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 1992;9:465-478.
78. Holtzman DM, Sheldon RA, Jaffe W, et al. Nerve growth factor protects the neonatal brain against hypoxic-ischemia injury. Ann Neurol 1996;39:114-122.
79. Houle JD, Ye JH, Kane CJM. Axonal regeneration by chronically injured supraspinal neurons can be enhanced by exposure to insulin-like growth factor, basic fibroblast growth factor or transforming growth factor beta. Restor Neurol Neurosci 1996,10:205-215.
80. Hu L, Cote SL, Cuello AC. Differential modulation of the cholinergic phenotype of the necleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields. Exp Neurol 1997;143:162-171.
81. Ikeda K, Iwasaki Y, Tagaya N, et al. Neuroprotective effect of cholinergic differentiation factor/ leukemia inhibitory factor on wobbler murine motor neuron disease. Muscle Nerve 1995;18: 1344-1347.
82. Kawakami N, Kashiwagi S, Kitahara T, et al. Effect of local administration of basic fibroblast growth factor against neuronal damage caused by transient intracerebral mass lesion in rats. Brain Res 1995;697:104-111.
83. Kawakami Y, Inoue A, Kawai T, et al. The rationale for E2020 as a potent acetylcholinesterase inhibitor. Bioorg Med Chem 1996;4: 1429-1446.
84. Kiss J, McGovern J, Patel AJ. Immunohistochemical localization of cells containing nerve growth factor receptors in different regions of the adult rat forebrain. Neuroscience 1988;27: 731-748.
85. Knusel B, Kaplan DR, Hefti F. Intraparenchymal NGF injections in adult and aged rats induce long-lasting Trk tyrosine phosphorylation. Exp Neurol 1996;139:121-130.
86. Kobayashi NR, Fan DP, Giehl KM, et al. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and alpha-1 tubulin mRNA expression, and promote axonal regeneration. J Neurosci 1997;17:9583-9595.
87. Koliatsos VE, Nauta HJ, Clatterbuck RE, et al. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J Neurosci 1990;10: 3801-3813.
88. Koliatsos VE, Applegate MD, Knusel B, et al. Recombinant human nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in rat. Exp Neurol 1991a;112:161-173.
89. Koliatsos VE, Clatterbuck RE, Nauta HJ, et al. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol 1991b;30:831-840.
90. Koo PH, Liebl DJ. Inhibition of nerve growth factor-stimulated neunte outgrowth by methylamine-modified a2-macroglobulin. J Neurosci Res 1992;31:678-692.
91. Kordower JH, Charles V, Bayer R, et al. Intravenous administration of a transferrin antibodynerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington's disease. Proc Natl Acad Sci USA 1994a,91:9077-9080.
92. Kordower JH, Winn SR, Liu Y-T, et al. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 1994b;91:10898-10902.
93. Korsching S, Auburger G, Heumann R, et al. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 1985;4:1389-1393.
94. Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science 1987;235:214-216.
95. Lange DJ, Felice KJ, Festoff BW, et al. Recombinant human insulin-like growth factor-I in ALS. Neurology 1996;47(Suppl):S93-S95.
96. Levi-Montalcini R, Arigeletti PU. Nerve growth factor. Physiol Rev 1968;48:534-569.
97. Levi-Montalcini R, Hamburger V. A diffusible agent of mouse sarcoma, producing hyperplasia of sympathetic ganglia and hyperneurotization of viscera in the chick embryo. J Exp Zool 1953;123:233-288.
98. Longo FM, Manthorpe M, Xie YM, et al. Synthetic NGF peptide derivatives prevent neuronal death via p75-dependent mechanisms. J Neurosci Res 1997;48:1-17.
99. Lonnerberg P, Soder O, Parvinen M, et al. Beta-nerve growth factor influences the expression of androgen-binding protein messenger ribonucleis acid in rat testis. Biol Reprod 1992;47:381-388.
100. Lu X, Hagg T. Glial cell-line derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats. J Comp Neurol 1997;388:484-494.
101. MacMillan V, Judge D, Wiseman A, et al. Mice expressing a bovine basic fibroblast growth factor transgene in the brain show increased resistance to hypoxic-ischemic cerebral damage. Stroke 1993;24:1735-1739.
102. Mamounas LA, Blue ME, Siuciak JA, et al. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995;15:7929-7939.
103. Markowska AL, Koliatsos VE, Breckler SJ, et al. Human nerve growth factor improves spatial memory in aged but not young rats. J Neurosci 1994;14:4815-4823.
104. Marshall JS, Stead RH, McSharry C, et al. The role of mast cell degranulation products in mast cell hyperplasia. I: mechanisms of action of nerve growth factor. J Immunol 1990;144: 1886-1892.
105. Martinez-Serrano A, Fischer W, Bjorklund A. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron 1995;15:473-484.
106. Martinez-Serrano A, Hantzopoulos PA, Bjorklund A. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons. Eur J Neurosci 1996;8:727-735.
107. Mazurek N, Weskamp G, Erne P, et al. Nerve growth factor induces mast cell degranulation without changing inttacellular calcium levels. FEBS Lett 1986;198:29-43.
108. McMahon SB, Armanini MP, Ling L, et al. Expression and coexpression of trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 1994;12:1161-1171.
109. Menesini-Chen MG, Chen JS, Levi-Montalcini R Sympathetic nerve fiber ingrowth in the central nervous system of neonatal rodents upon intracerebral NGF injections. Arch Ital Biol 1978;116:53-84.
110. Morse JK, Wiegand SJ, Anderson K, et al. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J Neurosci 1993;13.4146-4156.
111. Mount HTJ, Dean DO, Albrech J, et al. Dlial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells. Proc Natl Acad Sci USA 1995;92:9092-9096.
112. Mufson EJ, Conner JM, Kordower JH. Nerve growth factor in Alzheimer's disease - defective retrograde transport to nucleus basalis. Neuroreport 1995;6:1063-1066.
113. Near SL, Whalen LR, Miller JA, et al. Insulin-like growth factor II stimulates motor nerve regeneration. Proc Natl Acad Sci USA 1992;89:11716-11720.
114. Olson L, Nordberg A, von Holst H, et al. Nerve growth factor affects 11 C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer's patient (case report). J Neural Trans 1992;4:79-95.
115. Oppenheim RW, Prevette D, Qin-Wei Y, et al. Control of embryonic motorneuron survival in vivo by ciliary neurotrophic factor. Science 1991;251:1616-1618.
116. Oppenheim RW, Yin QW, Prevette D, et al. Brain-derived neurotrophic factor rescues developing avian motorneurons from cell death. Nature 1992;360:755-757.
117. Otto D, Frotscher M, Unsicker K. Basic fibroblast growth factor and nerve growth factor administered in gel foam rescue medial septal neurons after fimbria fornix transection. J Neurosci Res 1989;22:83-91.
118. Oudega M, Hagg T. Nerve growth factor promotes regeneration of sensory axons into adult rat spinal cord. Exp Neurol 1996;140:218-229.
119. Oudega M, Varon S, Hagg T. Regeneration of adult sensory axons into intraspinal grafts: promoting effects of conditioning lesion and graft pre-degeneration. Exp Neurol 1994;129: 194-206.
120. Parasuraman R, Greenwood PM, Haxby JV, et al. Visuospatial attention in dementia of the Alzheimer's type. Brain 1992;115:711-733.
121. Pechan PA, Yoshida T, Panahian N, et al. Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat. Neuroreport 1995;6:669-672.
122. Penn RD, Kroin JS, York MM, et al. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery 1997;40:94-99.
123. Perry EK, Perry RH, Blessed G, et al. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977;2:143-140.
124. Peterson DA, Lucidi-Phillipi CA, Murphy DP, et al. Fibroblast growth factor-2 protects entorhinal layer II glutamatergic neurons from axotomy-induced death. J Neurosci 1996;16: 886-898
125. Rabizadeh S, Oh J, Zhong L, et al. Induction of apoptosis by the low affinity NGF receptor. Science 1993;261:345-348.
126. Robertson K, Mason I. The GDNF-RET signalling partnership. Trends Genet 1997;13:1-3.
127. Ronne H, Anudi H, Rask L, et al. Nerve growth factor binds to serum alpha-2-macroglobulin. Biochem Biophys Res Commun 1979;87: 330-336.
128. Saffran BN, Woo JE, Mobley WC, et al. Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res 1989;492:245-254.
129. Sagot Y, Tan SA, Baetge E, et al. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur J Neurosci 1995;7:1313-1322.
130. Sagot Y, Tan SA, Hammang JP, et al. GDNF slows loss of motorneurons but not axonal degeneration or premature death of pmn/pmn mice. Neurosci 1996;16:2335-1341.
131. Sahakian BJ, Coull JT. Nicotine and tetrahydroaminoacridine: evidence for improved attention in patients with dementia of the Alzheimer's type. Drug Dev Res 1994;31:80-88.
132. Sauer H, Rosenblad C, Bjorklund A. Glil cell line-derived neurotrophic factor but not transforming growth factor beta-3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesions. Proc Natl Acad Sci USA 1995;92:8935-8939.
133. Schabitz WR, Schwab S, Spranger M, et al. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1997;17:500-506.
134. Schaumburg HH, Berger AR, Thomas PK. Anatomical classification of peripheral nervous system disorders. In: Schaumburg HH, Berger AR, Thomas PK, eds. Disorders of Peripheral Nerves. Philadelphia: FA Davis, 1992:10-24.
135. Schnell L, Schneider R, Kolbeck R, et al. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 1994;367:170-173.
136. Schumacher JM, Short MP, Hyman BT, et al. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 1991;45:561-570.
137. Segal RA, Greenberg ME. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 1996;19:463-489.
138. Sendtner M, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons after axotomy. Nature 1990; 345:440-449.
139. Sendtner M, Schmalbruch H, Stockli K, et al. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuropathy. Nature 1992; 358:502-505.
140. Shigeno T, Mima T, Takakura K, et al. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J Neurosci 1991;11:2914-2919.
141. Sjoberg J, Kanje M. Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res 1989;485:102-108.
142. The Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321:1364-1371.
143. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995;270:593-598.
144. Thoenen H, Barde Y-A. Physiology of nerve growth factor. Physiol Rev 1980;60:1285-1335.
145. Tomac A, Lindqvist E, Lin LF, et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995;373:335-339.
146. Tooyama I, Sasaki K, Oomura Y, et al. Effect of acidic fibroblast growth factor on basal forebrain cholinergic neurons in senescenceaccelerated mice. Exp Gerontol 1997;32:171-179.
147. Trupp M, Arenas E, Fainzilber M, et al. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 1996;381:785-788.
148. Tuszynski MH, Gage FH. Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system rescue and partial functional recovery. Proc Natl Acad Sci USA 1995;92:4621-4625.
149. Tuszynski MH, U H-S, Amaral DG, et al. Nerve growth factor infusions in primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 1990;10:3604-3614.
150. Tuszynski MH, U H-S, Gage FH. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann Neurol 1991;30:625-636.
151. Tuszynski MH, Peterson DA, Ray J, et al. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol 1994a;126:1-14.
152. Tuszynski MH, Senut M-C, Ray J, et al. Somatic gene transfer to the adult primate CNS: in vitro and in vivo characterization of cells genetically modified to secrete nerve growth factor. Neurobiol Dis 1994b;1:67-78.
153. Tuszynski MH, Mafong E, Meyer S. Central infusions of brain-derived neurotrophic factor and neurotrophin-4/5, but not nerve growth factor and neurotrophin-3, prevent loss of the cholinergic phenotype in injured adult motor neurons. Neurosci 1996a;71:761-771.
154. Tuszynski MH, Roberts J, Senut M-C, et al. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 1996b;3:305-314.
155. Ullrich A, Gray A, Berman C, et al. Human b-nerve growth factor gene sequences highly homologous to that of mouse. Nature 1983; 303:821-825.
156. Urfer R, Tsoulfas P, Soppet D, et al. The binding epitopes of neurotrophin-3 to its receptors trkC and gp75 and the design of a multifunctional human neurotrophin. EMBO J 1994;13: 5896-5909
157. Venero JL, Beck KD, Hefti F. Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA. Neurosci 1994;61:257-268.
158. Voytko ML. Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention? Behav Brain Res 1996;75:13-25.
159. Williams LR. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp Neurol 1991;113:31-37.
160. Williams LR, Varon S, Peterson GM, et al. Continuous infusion of nerve growth factor prevents forebrain neuronal death after fimbriafornix transection. Proc Natl Acad Sci USA 1986;83:9231-9235.
161. Williams LR, Jodehs KS, Donald MR. Axotomy-dependent stimulation of choline acetyltransferase activity by exogenous mouse nerve growth factor in adult rat basal forebrain. Brain Res 1989;488:243-266.
162. Winkler J, Ramirez GA, Kuhn HG, et al Induction of Schwann cell hyperplasia in vivo after intracerebroventricular administration of nerve growth factor. Soc Neurosci Abstr 1995;21: 278.
163. Winkler C, Sauer H, Lee CS, et al. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 1996;16:7206-7215.
164. Xu XM, Guenard V, Kleitman N, et al. A combination of BNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult thoracic spinal cords. Exp Neurol 1995;134:261-272.
165. Yamada K, Kinoshita A, Kohmura E, et al. Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. J Cereb Blood Flow Metab 1991;11:472-478.
166. Van Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992;360:753-755.
167. Van Q, Matheson C, Lopez OT, et al. The biological responses of axotomized adult motorneurons to brain-derived neurotrophic factor. J Neurosci 1994;14:5281-5291.
168. Yan Q, Matheson C, Lopez OT. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 1995;373: 341-344.
169. Ye JH, Houle JD. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp Neurol 1997;143:70-81.
170. Zhang Z, Miyoshi Y, Lapchak PA, et al. Dose response to intraventricular glial cell line-derived neurotrophic factor administration in Parkinsonian monkeys. J Pharmacol Exp Ther 1997;282:1396-1401.
171. Zhu CZ, Auer RN. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. J Cereb Blood Flow Metab 1994;14: 237-242.